ESTALIS 250/50 MCG
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ESTALIS 250/50 MCG in Canada?
A shortage of ESTALIS 250/50 MCG 50MCG 250MCG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 13, 2026), but it has not started yet.
Why is ESTALIS 250/50 MCG not available?
The reason the manufacturer reported: Demand increase for the drug.
When will ESTALIS 250/50 MCG be available again?
The manufacturer's estimated resolution date is February 28, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-02-28
~4 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02241837
Strength
50MCG 250MCG
Dosage Form
PATCH
Route
TRANSDERMAL
Active Ingredient
ESTRADIOL NORETHINDRONE ACETATE
Tier
Unrated
Last Updated
2026-10-13
Reason for Shortage
Demand increase for the drug.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759